Transforming big pharma [electronic resource] : assessing the strategic alternatives / John Ansell.
Material type:
BookPublication details: Farnham, Surrey : Gower Pub. Ltd., 2013.Description: xvi, 265 p. : illSubject(s): Genre/Form: DDC classification: - 338.4/76151 23
- HD9665.5 .A574 2013eb
| Item type | Current library | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
E-Books
|
Main Library | 338.4/76151 (Browse shelf(Opens below)) | Available | EB2967 |
Browsing Main Library shelves Close shelf browser (Hides shelf browser)
| No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available |
|
||
| 338.4/76095694 The evolution of a new industry | 338.4/7/61486 The costs of accidents | 338.4/76151 Devalued and distrusted | 338.4/76151 Transforming big pharma | 338.4/76151 Cracking the code | 338.4/76151 Innovation in the biopharmaceutical industry | 338.4/76151095195 The reconfiguration of a latecomer innovation system : |
Includes bibliographical references and index.
pt. I. How pharma differs and why this is important -- pt. II. Assessing management concepts for the pharmaceutical industry -- pt. III. Big pharma's strategic options -- pt. IV. Where will new products come from? -- pt. V. Prospects for new products -- pt. VI. Getting a true fix on prospects -- pt. VII. Conclusions and summary.
Electronic reproduction. Palo Alto, Calif. : ebrary, 2013. Available via World Wide Web. Access may be limited to ebrary affiliated libraries.
There are no comments on this title.